1. AB0267 Five-year safety and efficacy of golimumab in patients with active rheumatoid arthritis despite prior treatment with methotrexate: final study results of the phase 3, randomized placebo-controlled go-forward trial. (23rd January 2014) Authors: Keystone, E.; Genovese, M. C.; Hall, S.; Miranda, P. C.; Bae, S.-C.; Han, C.; Gathany, T.; Zhou, Y.; Xu, S.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0284 Long term safety of iv golimumab and comparisons with sc golimumab in rheumatologic conditions: results from the 120-day safety report of go-further trial. (23rd January 2014) Authors: Westhovens, R.; Bingham, C. O.; Weinblatt, M.; Fleischmann, R.; Keystone, E.; Hsia, E. C.; Hsu, B.; Kim, L.; Mudivarthy, S.; Mack, M.; Goldstein, N.; Braun, J.; Kavanaugh, A.; Mendelsohn, A.; Kay, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0513 Safety and efficacy of golimumab, a human anti-tnf monoclonal antibody injected subcutaneously every 4 weeks, in chinese patients with active ankylosing spondylitis: one-year results of a phase 3, randomized, placebo-controlled study. (23rd January 2014) Authors: Bao, C.; Huang, F.; Khan, M. A.; Fei, K.; Wu, Z.; Zhuang, Y.; Gathany, T.; Han, C.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A945 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0756 GUSELKUMAB IMPROVED WORK PRODUCTIVITY AND DAILY ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 TRIAL. (2nd June 2020) Authors: Curtis, J.; Mcinnes, I.; Rahman, P.; Tillett, W.; Mease, P. J.; Kollmeier, A.; Hsia, E. C.; Zhou, B.; Agarwal, P.; Peterson, S.; Han, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0801 EFFECTS OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF INTERLEUKIN-23, ON DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: POOLED RESULTS THROUGH WEEK 24 FROM TWO PHASE 3 STUDIES. (2nd June 2020) Authors: Mcgonagle, D.; Mcinnes, I.; Deodhar, A.; Schett, G.; Mease, P. J.; Shawi, M.; Kafka, S.; Karyekar, C.; Kollmeier, A.; Hsia, E. C.; Xu, X. L.; Sheng, S.; Agarwal, P.; Zhou, B.; Ritchlin, C. T.; Rahman, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1701 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0813 GUSELKUMAB-TREATED PATIENTS ACHIEVED CLINICALLY MEANINGFUL IMPROVEMENT IN SYSTEMIC SYMPTOMS AS MEASURED WITH PROMIS INSTRUMENT: RESULTS FROM PHASE-3 PSORIATIC ARTHRITIS TRIAL DISCOVER 1. (2nd June 2020) Authors: Orbai, A. M.; Coates, L. C.; Deodhar, A.; Helliwell, P.; Ritchlin, C. T.; Kollmeier, A.; Hsia, E. C.; Xu, X. L.; Sheng, S.; Zhou, B.; Han, C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB1332-HPR ASSESSING THE PATIENT EXPERIENCE OF LUPUS NEPHRITIS: DEVELOPMENT OF A CONCEPTUAL MODEL AND REVIEW OF EXISTING PATIENT-REPORTED OUTCOME (PRO) MEASURES. (2nd June 2020) Authors: Berry, P.; Burrows, K.; Hall, R.; Gater, A.; Bradley, H.; Ward, A.; Tolley, C.; Delong, P.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1954 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0178 Five-year safety and efficacy of golimumab in methotrexate-naïve patients with rheumatoid arthritis: final study results of the phase 3, randomized, placebo-controlled go-before trial. (23rd January 2014) Authors: Emery, P.; Fleischmann, R. M.; Strusberg, I.; Durez, P.; Nash, P.; Amante, E.; Churchill, M.; Park, W.; Pons-Estel, B.; Han, C.; Gathany, T.; Zhou, Y.; Xu, S.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0211 Safety and efficacy of subcutaneous golimumab in chinese patients with active rheumatoid arthritis despite mtx therapy: results from a randomized, placebo-controlled, phase 3 trial. (23rd January 2014) Authors: Li, Z.; Zhang, F.; Kay, J.; Fei, K.; Han, C.; Zhuang, Y.; Wu, Z.; Hsia, E. C. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0359 INTEGRATED SAFETY RESULTS OF TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH THE PLACEBO-CONTROLLED PERIODS. (2nd June 2020) Authors: Rahman, P.; Ritchlin, C. T.; Helliwell, P.; Boehncke, W. H.; Mease, P. J.; Gottlieb, A. B.; Kafka, S.; Kollmeier, A.; Hsia, E. C.; Xu, X. L.; Shawi, M.; Sheng, S.; Agarwal, P.; Zhou, B.; Ramachandran, P.; Mcinnes, I. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗